Rx Medicare

U.S. Congressman Jason Altmire (PA-04), U.S. Congressman Tim Murphy (PA-18) and U.S. Congresswoman Anna Eshoo (CA-14) introduced legislation that will improve patients’ access to life-saving diagnostic tests. The Patient Access to Critical Lab Tests Act (H.R. 1699) will eliminate burdensome Medicare billing regulations that often discourage hospitals from ordering lab tests that can clarify complicated diagnoses and identify uniquely effective methods of treatment.

Read More…

Related Posts

• National Community Pharmacists Association Applauds House Of Representatives For Passing Bill Maintaining Seniors’ Access To Durable Medical Equipment
• IMPROVE Bill Seeks To Fight Medicare Fraud
• Life-Saving Cardiac Rehabilitation
• Preserving Patient Access To Primary Care Act Of 2009 Endorsed By American College Of Physicians
• Reps. Introduce Bill To Expand Medicaid Coverage To Some HIV-Positive People
• Health Bill Deal ‘Close’ Though Some Democrats – And All Republicans – Hold Out
• Senate Test Vote Today On Bill To Extend COBRA Subsidy, Doc Fix And State Medicaid Funding
• Obama Builds On Senate Health Bill In Hopes Of Broader Support
• Jobs Bill Missing Medicaid Money For States, Governors Call For Change
• Neb. Clears Path For Consideration Of Bill Providing Prenatal Care To Undocumented Immigrants
• Aetna Medicare Members To Have Access To Pharmacists Who Can Help Them Safely And Effectively Take Medicines
• Medicaid Cuts, Past And Proposed, A Concern To Businesses And Patient Advocates
• Virginia AG Works To Increase Outpatient Treatment For Mentally Ill; Iowa Hospitals Oppose Medicare Fraud Bill
• Pelosi Says House Could Pass Senate Bill Under Two-Track Approach
• With Federal Health Bill Stalled, California Senate To Vote On Comprehensive, Medicare For All Healthcare Reform

Tags: access, altmire, bill, easing, eshoo, improve, introduce, life, murphy, patient, saving, tests

This entry was posted on Sunday, March 29th, 2009 at 10:03 pm and is filed under Uncategorized. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.